Rice Hall James & Associates LLC Purchases New Position in Transcat, Inc. $TRNS

Posted by on Aug 18th, 2026

Rice Hall James & Associates LLC purchased a new position in Transcat, Inc. (NASDAQ:TRNS – Free Report) in the second quarter, HoldingsChannel reports. The fund purchased 56,325 shares of the scientific and technical instruments company’s stock, valued at approximately $5,225,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. Wellington Management Group LLP boosted its position in Transcat by 677.7% during the 4th quarter. Wellington Management Group LLP now owns 248,539 shares of the scientific and technical instruments company’s stock valued at $14,100,000 after acquiring an additional 216,579 shares in the last quarter. First Eagle Investment Management LLC bought a new position in shares of Transcat in the 4th quarter worth approximately $7,259,000. King Luther Capital Management Corp lifted its stake in shares of Transcat by 182.3% in the 4th quarter. King Luther Capital Management Corp now owns 103,750 shares of the scientific and technical instruments company’s stock valued at $5,886,000 after purchasing an additional 67,000 shares during the period. Royce & Associates LP boosted its position in shares of Transcat by 15.3% during the fourth quarter. Royce & Associates LP now owns 390,546 shares of the scientific and technical instruments company’s stock valued at $22,156,000 after purchasing an additional 51,774 shares in the last quarter. Finally, Renaissance Technologies LLC boosted its position in shares of Transcat by 109.7% during the fourth quarter. Renaissance Technologies LLC now owns 95,200 shares of the scientific and technical instruments company’s stock valued at $5,401,000 after purchasing an additional 49,800 shares in the last quarter. 98.34% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Transcat

In other news, Director Christopher P. Gillette sold 504 shares of the firm’s stock in a transaction on Friday, August 7th. The stock was sold at an average price of $94.23, for a total transaction of $47,491.92. Following the completion of the transaction, the director directly owned 200 shares in the company, valued at $18,846. This trade represents a 71.59% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Craig D. Cairns purchased 1,050 shares of the stock in a transaction dated Thursday, August 6th. The stock was bought at an average cost of $93.97 per share, with a total value of $98,668.50. Following the transaction, the director owned 1,480 shares in the company, valued at $139,075.60. The trade was a 244.19% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders own 1.80% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have issued reports on TRNS shares. Wall Street Zen upgraded Transcat from a “sell” rating to a “hold” rating in a report on Sunday, June 28th. Weiss Ratings upgraded shares of Transcat from a “sell (d)” rating to a “sell (d+)” rating in a report on Thursday, May 28th. Zacks Research raised shares of Transcat from a “strong sell” rating to a “hold” rating in a research report on Friday, May 15th. Finally, Northland Securities lowered shares of Transcat from an “outperform” rating to a “market perform” rating and set a $95.00 price target for the company. in a research note on Wednesday, August 5th. One investment analyst has rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Transcat currently has an average rating of “Hold” and a consensus target price of $105.50.

Check Out Our Latest Analysis on TRNS

Transcat Price Performance

TRNS stock opened at $93.84 on Tuesday. The company has a debt-to-equity ratio of 0.36, a quick ratio of 2.11 and a current ratio of 2.49. The firm has a 50 day moving average price of $90.13 and a 200-day moving average price of $81.07. Transcat, Inc. has a 52-week low of $50.23 and a 52-week high of $100.00. The firm has a market capitalization of $878.34 million, a price-to-earnings ratio of 253.62 and a beta of 0.68.

Transcat (NASDAQ:TRNS – Get Free Report) last posted its quarterly earnings results on Tuesday, August 4th. The scientific and technical instruments company reported $0.51 earnings per share for the quarter, topping the consensus estimate of $0.38 by $0.13. Transcat had a return on equity of 5.56% and a net margin of 0.99%.The company had revenue of $92.95 million for the quarter, compared to the consensus estimate of $86.55 million. Equities research analysts forecast that Transcat, Inc. will post 1.74 EPS for the current fiscal year.

About Transcat

(Free Report)

Transcat, Inc (NASDAQ: TRNS) is a leading provider of calibration, laboratory, and metrology services in North America. Founded in 1964 and headquartered in Ronkonkoma, New York, the company specializes in ensuring the accuracy and compliance of measurement instruments across a wide range of industries. Transcat operates a network of ISO/IEC 17025–accredited laboratories and offers on-site field calibration, instrument repair, and preventive maintenance services.

In addition to its calibration services, Transcat distributes precision instrumentation and related software solutions from top manufacturers.

Read More

Want to see what other hedge funds are holding TRNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Transcat, Inc. (NASDAQ:TRNS – Free Report).

Institutional Ownership by Quarter for Transcat (NASDAQ:TRNS)

Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.